Catalyst Wire Dossier Catalyst Wire Dossier

ALVAC-HIV vaccine (clade C)

canarypox vector-based HIV vaccine
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ALVAC-HIV vaccine (clade C), covering 2021-02-18 to 2021-02-18. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Immunogenicity of Clade C ALVAC and gp120 HIV Vaccine [Phase 1, Phase 2]

See pricing